Related Experiment Video
Updated: Jun 16, 2026
05:36
Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
Optimizing iron chelation strategies in beta-thalassaemia major
1Department of Haematology, University College London, London, UK. j.porter@ucl.ac.uk
Blood Reviews
|February 2, 2010
Summary
Beta-thalassaemia management relies on iron chelation therapy to prevent complications from iron overload. Recent advances focus on deferasirox, an oral chelator demonstrating efficacy and safety in adults and children for reducing iron levels, including in the myocardium.
Area of Science:
- Hematology
- Pharmacology
- Internal Medicine
Background:
- Beta-thalassaemia necessitates lifelong blood transfusions, leading to iron overload.
- Iron overload causes significant organ damage, particularly in the liver and heart.
- Chelation therapy is crucial for managing transfusional iron overload and its complications.
Purpose of the Study:
- To review recent advances in iron chelation therapy for beta-thalassaemia.
- To highlight the efficacy and safety of deferasirox, an oral iron chelator.
- To discuss individualized chelation strategies based on iron load and transfusion rates.
Main Methods:
- Review of large-scale prospective trials on deferasirox.
- Analysis of safety and efficacy data in adults and children with up to 5 years follow-up.
- Evaluation of deferasirox dosing strategies based on serum ferritin levels and transfusion rates.
Main Results:
- Deferasirox demonstrates efficacy and an acceptable safety profile in adults and children.
- Specific dosing guidelines for deferasirox are established based on serum ferritin levels.
- Deferasirox effectively reduces myocardial iron levels, a key indicator of cardiac iron overload.
Conclusions:
- Iron chelation therapy is essential for managing beta-thalassaemia and preventing iron overload complications.
- Deferasirox offers a safe and effective oral option for iron chelation in beta-thalassaemia patients.
- Individualized treatment strategies, including optimal deferasirox dosing, are critical for effective iron management.
Related Concept Videos
00:56Extraction: Advanced Methods
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is formed in...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:22EDTA: Chemistry and Properties
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
01:19Complexation Equilibria: The Chelate Effect
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
01:19Masking and Demasking Agents
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...